Hikari Power Ltd - CORVUS PHARMACEUTICALS INC ownership

CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 67 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.

Quarter-by-quarter ownership
Hikari Power Ltd ownership history of CORVUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$73
-36.0%
49,9590.0%0.01%
-36.4%
Q2 2023$114
+153.3%
49,9590.0%0.01%
+120.0%
Q1 2023$45
+7.1%
49,9590.0%0.01%
+25.0%
Q4 2022$42
-99.9%
49,9590.0%0.00%
-20.0%
Q3 2022$41,000
-16.3%
49,9590.0%0.01%0.0%
Q2 2022$49,000
-40.2%
49,9590.0%0.01%
-28.6%
Q1 2022$82,000
+70.8%
49,959
+150.3%
0.01%
+75.0%
Q4 2021$48,000
-50.5%
19,9590.0%0.00%
-60.0%
Q3 2021$97,000
+83.0%
19,9590.0%0.01%
+100.0%
Q2 2021$53,000
-13.1%
19,9590.0%0.01%
-16.7%
Q1 2021$61,000
-14.1%
19,9590.0%0.01%
-25.0%
Q4 2020$71,000
-11.2%
19,9590.0%0.01%
-20.0%
Q3 2020$80,000
-51.8%
19,959
-67.3%
0.01%
-56.5%
Q2 2020$166,000
+28.7%
60,9590.0%0.02%
+27.8%
Q1 2020$129,000
-70.3%
60,959
-23.8%
0.02%
-60.0%
Q4 2019$435,000
+11.3%
80,000
-38.5%
0.04%
+7.1%
Q3 2019$391,000
-19.5%
130,0000.0%0.04%
-19.2%
Q2 2019$486,000
-7.1%
130,0000.0%0.05%
-5.5%
Q1 2019$523,000
+9.6%
130,0000.0%0.06%
+1.9%
Q4 2018$477,000
+73.5%
130,000
+305.1%
0.05%
+92.9%
Q3 2018$275,00032,0900.03%
Other shareholders
CORVUS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
ADAMS STREET PARTNERS LLC 3,275,616$4,782,3991.67%
TOWERVIEW LLC 342,478$500,0180.33%
Orbimed Advisors 6,943,654$10,137,7350.22%
SAMLYN CAPITAL, LLC 2,405,764$3,512,4150.06%
BVF INC/IL 1,370,947$2,001,5830.05%
JACKSON SQUARE CAPITAL, LLC 63,773$93,1090.04%
MYDA Advisors LLC 68,814$100,4680.03%
Masso Torrence Wealth Management Inc. 10,000$14,6000.01%
Hikari Power Ltd 49,959$730.01%
XTX Topco Ltd 19,244$28,0960.01%
View complete list of CORVUS PHARMACEUTICALS INC shareholders